Sentante
Latvian medical device company
Sentante has raised €6.0M across 1 funding round from 2 investors, most recently a Seed round in Dec 2023. Based in Riga, Latvia; active in Healthtech. Data as of 4 Nov 2026.
Riga, Latviasentante.com ↗
Total raised
€6.0M
€6,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2023-12
latest 2023-12
Funding by year
EUR raised per yearSentante — funding by year — interactive chart.
Data table
| Sentante — funding by year | |
|---|---|
| 2023 | €6.0M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Seed
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-12-21 | Seed | €6.0M | EIC Fund,Practica Capital | View deal → |
Investors
2Related news
Similar companies
same sector, similar size- InProTher€6.0MDenmark · Healthtech
- HeartBeat.bio€6.0MAustria · Healthtech
- MVision AI€6.0MFinland · Healthtech
- Jude€6.3MUK · Healthtech
- Actimed Therapeutics€5.7MUK · Healthtech
- Pencil Biosciences€6.5MUK · Healthtech
Global coverage: FundingData